These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 19458955)
1. Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma. Lim MC; Lee HS; Kang S; Seo SS; Lee BY; Park SY Arch Gynecol Obstet; 2010 Feb; 281(2):329-34. PubMed ID: 19458955 [TBL] [Abstract][Full Text] [Related]
2. When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes. Duska LR; Garrett L; Henretta M; Ferriss JS; Lee L; Horowitz N Gynecol Oncol; 2010 Mar; 116(3):374-7. PubMed ID: 19922988 [TBL] [Abstract][Full Text] [Related]
3. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J; J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180 [TBL] [Abstract][Full Text] [Related]
4. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer. Black D; Iasonos A; Ahmed H; Chi DS; Barakat RR; Abu-Rustum NR Gynecol Oncol; 2007 Oct; 107(1):66-70. PubMed ID: 17614125 [TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival. Diaz ES; Walts AE; Karlan BY; Walsh CS Gynecol Oncol; 2013 Dec; 131(3):541-5. PubMed ID: 24041880 [TBL] [Abstract][Full Text] [Related]
6. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival. Abu-Rustum NR; Richard S; Wilton A; Lev G; Sonoda Y; Hensley ML; Gemignani M; Barakat RR; Chi DS Gynecol Oncol; 2005 Nov; 99(2):320-6. PubMed ID: 16061278 [TBL] [Abstract][Full Text] [Related]
7. Characteristic and prognostic implication of venous thromboembolism in ovarian clear cell carcinoma: a 12-year retrospective study. Ye S; Yang J; Cao D; Bai H; Huang H; Wu M; Chen J; You Y; Lang J; Shen K PLoS One; 2015; 10(3):e0121818. PubMed ID: 25793293 [TBL] [Abstract][Full Text] [Related]
8. High incidence of silent venous thromboembolism before treatment in ovarian cancer. Satoh T; Oki A; Uno K; Sakurai M; Ochi H; Okada S; Minami R; Matsumoto K; Tanaka YO; Tsunoda H; Homma S; Yoshikawa H Br J Cancer; 2007 Oct; 97(8):1053-7. PubMed ID: 17895896 [TBL] [Abstract][Full Text] [Related]
9. Association of clear cell carcinoma of the endometrium with a high rate of venous thromboembolism. Lee L; Garrett L; Lee H; Oliva E; Horowitz N; Duska LR J Reprod Med; 2009 Mar; 54(3):133-8. PubMed ID: 19370896 [TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry. Arcelus JI; Monreal M; Caprini JA; Guisado JG; Soto MJ; Núñez MJ; Alvárez JC; Thromb Haemost; 2008 Mar; 99(3):546-51. PubMed ID: 18327403 [TBL] [Abstract][Full Text] [Related]
11. Laparoscopic surgery is associated with a lower incidence of venous thromboembolism compared with open surgery. Nguyen NT; Hinojosa MW; Fayad C; Varela E; Konyalian V; Stamos MJ; Wilson SE Ann Surg; 2007 Dec; 246(6):1021-7. PubMed ID: 18043105 [TBL] [Abstract][Full Text] [Related]
16. Rates of venous thromboembolism occurrence in medical patients among the insured population. Spyropoulos AC; Hussein M; Lin J; Battleman D Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534 [TBL] [Abstract][Full Text] [Related]
17. The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer. Sandhu R; Pan CX; Wun T; Harvey D; Zhou H; White RH; Chew HK Cancer; 2010 Jun; 116(11):2596-603. PubMed ID: 20336780 [TBL] [Abstract][Full Text] [Related]
18. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice. Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E; Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976 [TBL] [Abstract][Full Text] [Related]
19. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Kakkar AK; Cohen AT; Tapson VF; Bergmann JF; Goldhaber SZ; Deslandes B; Huang W; Anderson FA; Ann Surg; 2010 Feb; 251(2):330-8. PubMed ID: 20054273 [TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials. Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]